- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00250315
DOCICAR: Cardiac Dysfunction in Cirrhosis
October 31, 2007 updated by: Hvidovre University Hospital
Cardiac Dysfunction in Cirrhosis: Cirrhotic Cardiomyopathy Evaluated by Dobutamin MRI.
Patients with cirrhosis have a altered cardiac response to stress.
This study evaluate the cardiac response by MRI during dobutamine stress.
Hypothesis: impared increase in cardiac output, cardiac index, ejection fraction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hvidovre
-
Copenhagen, Hvidovre, Denmark, 2650
- Hvidovre University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Non alkoholic cirrhosis
Exclusion Criteria:
- Coma hepaticum
- Primary cardiac diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Søren Møller, DrMsci, MD, Hvidovre University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2005
Study Completion (Actual)
October 1, 2007
Study Registration Dates
First Submitted
November 4, 2005
First Submitted That Met QC Criteria
November 4, 2005
First Posted (Estimate)
November 8, 2005
Study Record Updates
Last Update Posted (Estimate)
November 1, 2007
Last Update Submitted That Met QC Criteria
October 31, 2007
Last Verified
October 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Liver Diseases
- Fibrosis
- Liver Cirrhosis
- Cardiomyopathies
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Protective Agents
- Adrenergic Agonists
- Cardiotonic Agents
- Adrenergic beta-Agonists
- Sympathomimetics
- Adrenergic beta-1 Receptor Agonists
- Dobutamine
Other Study ID Numbers
- (KF) 01 270675
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cirrhosis
-
Postgraduate Institute of Medical Education and...Society for the Study of Liver Diseases, Chandigarh ( India )UnknownDecompensated Cirrhosis of LiverIndia
-
University Health Network, TorontoUnknown
-
National Institute of Diabetes and Digestive and...National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Cancer... and other collaboratorsRecruitingCirrhosis | Cirrhosis, Liver | Cirrhosis Due to Hepatitis B | Cirrhosis Due to Hepatitis C | Cirrhosis Early | Cirrhosis Advanced | Cirrhosis Infectious | Cirrhosis Alcoholic | Cirrhosis, Biliary | Cirrhosis Cryptogenic | Cirrhosis Due to Primary Sclerosing CholangitisUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingPrimary Biliary CirrhosisChina
-
RenJi HospitalNot yet recruiting
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
Institute of Liver and Biliary Sciences, IndiaRecruiting
-
SUUMC Central Military Hospital Dr Carol DavilaRecruiting
-
The Cleveland ClinicRecruiting
-
Beijing 302 HospitalLanZhou University; Chinese PLA General Hospital; Renmin Hospital of Wuhan University and other collaboratorsRecruitingDecompensated CirrhosisChina
Clinical Trials on Dobutamine
-
University of Sao PauloCompletedCoronary Disease | Cardiac Output, LowBrazil
-
University of Sao Paulo General HospitalUnknownHeart Failure | Cardiogenic Shock
-
Sichuan UniversityNot yet recruitingLaparoscopic HepatectomyChina
-
Medstar Health Research InstituteNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Coronary Disease | Heart Failure, Congestive
-
University Hospital TuebingenFördergemeinschaft Deutsche Kinderherzzentren, Bonn, GermanyCompletedRight Ventricular DysfunctionGermany
-
University of AvignonCompletedDiabetes-related ComplicationsFrance
-
University Health Network, TorontoNot yet recruiting
-
Steen Hvitfeldt PoulsenRecruitingAortic Stenosis | Transthyretin Amyloid CardiomyopathyDenmark
-
Odense University HospitalUniversity of Southern Denmark; Region of Southern DenmarkRecruitingAortic Valve Stenosis | Valvular Heart Disease | Valvular StenosisDenmark
-
University Hospital, GhentCompletedGeneral AnesthesiaBelgium